Smith & Nephew plc (SNN) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
SNN Revenue Growth
Revenue Breakdown (FY 2024)
SNN's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
By Geography
SNN Revenue Analysis (2014–2025)
As of May 8, 2026, Smith & Nephew plc (SNN) generated trailing twelve-month (TTM) revenue of $11.61 billion, reflecting solid growth of +5.7% year-over-year. The most recent quarter (Q2 2025) recorded $2.99 billion in revenue, up 0.2% sequentially.
Looking at the longer-term picture, SNN's 5-year compound annual growth rate (CAGR) stands at +6.3%, indicating steady revenue expansion. The company achieved its highest annual revenue of $6.18 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows SNN's business is primarily driven by Orthopaedics, Sports Medicine and ENT and Advanced Wound Management (50%), Orthopaedics, Sports Medicine and Ear Nose and Throat (36%), and Advanced Wound Management (14%).
When compared to Healthcare sector peers including ZBH (+9.2% YoY), SYK (+11.2% YoY), and BSX (+19.9% YoY), SNN has underperformed the peer group in terms of revenue growth. Compare SNN vs ZBH →
SNN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SNNCurrent | $11.6B | +5.7% | +6.3% | 16.3% | |
 ZBH | $8.2B | +9.2% | +6.1% | 16.5% | |
 SYK | $25.1B | +11.2% | +11.8% | 19.5% | |
 BSX | $20.1B | +19.9% | +15.2% | 19.8% | |
 HOLX | $4.1B | +2.2% | +1.7% | 17.4% | |
 CNMD | $1.4B | +4.4% | +9.8% | 10.3% |
SNN Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $6.18B | +6.3% | $4.20B | 68.0% | $1.01B | 16.3% |
| 2024 | $5.81B | +4.7% | $4.05B | 69.6% | $657.0M | 11.3% |
| 2023 | $5.55B | +6.4% | $3.82B | 68.8% | $425.0M | 7.7% |
| 2022 | $5.21B | +0.1% | $3.67B | 70.5% | $315.0M | 6.0% |
| 2021 | $5.21B | +14.3% | $3.67B | 70.4% | $593.0M | 11.4% |
| 2020 | $4.56B | -11.2% | $3.16B | 69.4% | $295.0M | 6.5% |
| 2019 | $5.14B | +4.8% | $3.80B | 74.0% | $815.0M | 15.9% |
| 2018 | $4.90B | +2.9% | $3.61B | 73.5% | $863.0M | 17.6% |
| 2017 | $4.76B | +2.1% | $3.52B | 73.8% | $934.0M | 19.6% |
| 2016 | $4.67B | +0.8% | $3.40B | 72.8% | $801.0M | 17.2% |
Full SNN Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See SNN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SNN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SNN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSNN — Frequently Asked Questions
Quick answers to the most common questions about buying SNN stock.
Is SNN's revenue growth accelerating or slowing?
SNN maintains +5.7% revenue growth, in line with its 5-year CAGR of +6.3%. TTM revenue stands at $11.6B. Growth rate remains consistent with historical average.
What is SNN's long-term revenue growth rate?
Smith & Nephew plc's 5-year revenue CAGR of +6.3% reflects the sustained expansion pattern. Current YoY growth of +5.7% is near this long-term average.
How is SNN's revenue distributed by segment?
SNN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.